Cancer Center in Michigan | Beaumont Cancer Treatment Options

News:

Shelly Parpart got a second opinion after she was diagnosed with pancreatic cancer. The 37-year-old mother returned to Beaumont because it offered more cancer treatment options, including an experimental vaccine, the first new option to treat pancreatic cancer in 30 years.

The vaccine is a welcome development because pancreatic tumors are the fourth leading cause of cancer death in the United States, with a survival time averaging 18-24 months. The disease appears in women and men about equally.

Read More

When Tami Marinello had genetic testing in August 2009 to determine her risk for breast and ovarian cancer, her results were no surprise to her.

By the time her blood was drawn for testing, her mom, aunt, uncle and four cousins – all on her mother’s side of the family – all had had breast cancer. Tragically, the same aunt who had breast cancer mistakenly thought she had her ovaries removed in a complete hysterectomy. She was subsequently diagnosed with ovarian cancer.

Read More

Beaumont Hospital, Troy has opened a 13,000-square-foot outpatient radiation oncology department that completes the consolidation of the hospital’s outpatient cancer services in an expanded Cancer Center on its Sterling Heights campus.

“With the opening of the new radiation oncology unit, we are able to offer all of the outpatient services needed by cancer patients in one convenient location to improve the patient experience,” says Eric Brown, M.D., director of Oncology Services and the Breast Care Center at Beaumont, Troy.

Read More

1 | 2 | 3

After two surgeries and many years, Mary Ann Jarrett’s aggressive, bone tumor reappeared. The cancer at the base of her skull had to be removed and the only option to access her tumor was through her mouth.	Silver Linings Helps Women Cancer Survivors Through Their Journey Silver Linings is designed for women who have survived any type of cancer, regardless of where they received treatment.

Cancer Genetics Program

It is important to identify families with a hereditary susceptibility to cancer because in many cases, they may take steps to reduce their risk or prevent cancer from occurring.

Beaumont's Cancer Genetics program in Michigan provides patients with the most up-to-date information about hereditary cancer risk and guidelines for cancer screening and treatment. Our strategies have clearly been shown to lead to earlier detection of cancer, better treatment options, and improved outcomes.